Sorry, no content matched your criteria.
Featured Story
Teva Finally Puts a Number on Mylan Deal, Investors Stand to Profit
Teva is a 114-year old maker of pharmaceutical generics, and they've generated lots of cash along the way. They've been coy about their intention to purchase Mylan, but now there's a healthy number on the table, and share prices are on the way up...
Teva is a 114-year old maker of pharmaceutical generics, and they've generated lots of cash along the way. They've been coy about their intention to purchase Mylan, but now there's a healthy number on the table, and share prices are on the way up...